OM:GETI BMedical Equipment
Getinge (OM:GETI B): Assessing Valuation as Guidance Holds Firm Despite Tariffs and Currency Pressures
Getinge (OM:GETI B) reaffirmed its guidance for 2025, confirming expectations for 2% to 5% organic net sales growth and targeting over 12% earnings per share growth, even with ongoing headwinds from tariffs and currency shifts.
See our latest analysis for Getinge.
Backed by steady guidance and resilience in the face of tariffs and currency changes, Getinge’s shares have climbed with conviction this year, posting a robust 21.6% year-to-date share price return and an impressive 1-year total...